COMPSTUDY
RECENT SEARCHES
CASE STUDIES
WHITE PAPERS
EVENTS
About Life Sciences
Representative Clients
Affymetrix
Aileron
Biogen IDEC
BiPar Sciences
Enlight Biosciences
Genocea Biosciences
Ironwood Pharmaceuticals
miRagen Therapeutics
Trius Therapeutics
Vical

The Life Sciences industry has a rich history of dynamic transformations.  As M&A deals and R&D collaborations become increasingly prevalent as means of driving value, the industry has grown in size and global complexity. As this trend continues, new strategies are emerging as to how to best bring innovation to healthcare.  Products, technology, and operational excellence continue to drive the sector forward, and the leadership of Life Sciences organizations must increasingly deliver value in the face of escalating costs and changing government policy.  At the core of the mission remains a dedication to helping the lives of patients through scientific advancements.
Practice Overview

Our Life Sciences practice has been a leader in delivering the human capital solutions that have driven the profound evolution taking place in the industry for over 25 years.  We serve Boards, Financial Sponsors and Executive Teams as trusted advisors on their most critical talent challenges. We do this by bringing a rigorous approach to research, intellectually honest assessments and deep industry expertise to bear on our client assignments. Our experienced team leverages dedicated research and robust candidate development that provides a customized, expedient and meaningful solution. Our commitment to a quality outcome is palpable throughout the client’s experience in working with us and is evidenced by our completion rate of 75%.  Our practice prides itself on domain experience spanning almost every segment of the vibrant Life Sciences market: Therapeutics, Personalized Medicine, Specialty Pharmaceuticals, Medical Devices, Tools and Instruments, Diagnostics, Agribiotechnology, Academic Medicine and Healthcare Services.

Compensation Study

Besides our dedicated search efforts to best serve our clients, J. Robert Scott also proudly presents CompStudy, an annual report of equity and cash compensation. It provides authoritative compensation data on top management positions and Boards of Directors at private, venture funded companies in technology and life sciences.  The study, in its 12th year, is produced by professionals at J. Robert Scott and Ernst & Young, in collaboration with academics from the Harvard Business School.

The study results provide essential information for businesses and investors to stay abreast of current trends in senior executive compensation and organizational structures.   Data is analyzed in aggregate with detailed views by position.  The volume of responses all for slices on the data by: founder/non-founder status, company revenue and headcount, geography, business segment, and number of financing rounds raised.  Additional detail is provided on compensation for the Board of Directors, general organizational changes over time and other compensation trends.

For more information, please visit https://compstudy.com/.


Stacey Detrick-Lerner Stacey Detrick-Lerner
Director
Life Sciences
Bruce Rychlik Bruce Rychlik
Managing Director
Life Sciences, Education | Not For Profit
Jonathan Fortescue Ph.D. Jonathan Fortescue Ph.D.
Managing Director
Life Sciences, Education | Not For Profit
Richard von Rueden M.D. Richard von Rueden M.D.
Managing Director
Life Sciences, Education | Not For Profit
Erik Lundh Erik Lundh
Managing Director
Life Sciences
Jonathan Zhu Jonathan Zhu
Director
Life Sciences
Sara Smith Sara Smith
Senior Associate
Life Sciences
Jesse Hershman Jesse Hershman
Researcher
Life Sciences
Margery Long Margery Long
Practice Administrator
Life Sciences
Sadie Rubyn Sadie Rubyn
Practice Administrator
Life Sciences